Godae Ansan Hospital and Theragen Bio Sign MOU for 'Genomic Data Research'
Korea University Ansan Hospital announced on the 10th that it signed a Memorandum of Understanding (MOU) with Theragen Bio, a global genome analysis service and platform-based new drug development company, on the 6th.
Hwang Tae-soon, CEO of Theragen Bio (left), and Lee Joo-han, Research Director of Korea University Ansan Hospital, are taking a commemorative photo after signing a business agreement at Theragen Bio headquarters in Pangyo, Gyeonggi-do on the 6th. Photo by Korea University Ansan Hospital
View original imageThe signing ceremony took place at Theragen Bio's headquarters in Pangyo, Gyeonggi-do, attended by Lee Joo-han, Vice Director of Research at Korea University Ansan Hospital, professors Seong Hwa-jung and Choi Jung-yoon from the Department of Hematology and Oncology, Theragen Bio CEO Hwang Tae-soon, Research Director Baek Soon-myung, and about 10 other officials.
Through this agreement, both institutions will establish a mutual cooperation system for ▲ production and provision of precision genome data ▲ collaboration on the latest precision medical services such as Single Cell genome and Spatial Transcriptome ▲ discovery and collaboration on joint research projects.
Theragen Bio produces and provides high-quality genome information based on over 10 years of accumulated know-how and technology. Korea University Ansan Hospital plans to utilize this data to discover tumor-related research projects and advance cancer research.
Lee Joo-han, Vice Director of Research at Korea University Ansan Hospital, said, "Securing the latest data is important to realize precision medicine," adding, "We will work to discover related research projects and collaborate with the global genome analysis company Theragen Bio to advance cancer research."
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Baek Soon-myung, Research Director at Theragen Bio, stated, "The importance of securing high-quality genome information data through the latest technology in cancer research continues to increase," and added, "Through the high-quality data provided by Theragen Bio, we will be able to contribute to cancer research at Korea University Ansan Hospital."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
